Abstract

32P Efficacy and safety of furmonertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: A real-world retrospective study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call